new issue
Jul 20
P2Y12 inhibitor monotherapy after complex PCI; ticagrelor monotherapy in STEMI; endotype-based treatment in ANOCA; vasomotor dysfunction after PCI; collapse of a new-generation magnesium scaffold; and more
Flashlight
Jul 20
Teresa Bastante, Fernando Alfonso, et al.
A 71-year-old male with non-ST-segment elevation myocardial infarction was treated with a bioresorbable magnesium scaffold, but developed severe in-stent restenosis at 6 months due to scaffold collapse, confirmed by OCT and IVUS.
Flashlight
Jul 17
Ioannis Lianos, Simon Redwood, et al.
This article describes the successful performance of a combined transfemoral transcatheter aortic valve implantation and transfemoral/transseptal transcatheter mitral valve replacement in a high-risk patient with severe mitral and aortic stenosis.
Research Correspondence
Jul 16
Nahyr Sofía Lugo-Fagundo, Abdallah El Sabbagh, et al.
This retrospective study evaluated the use of catheter-based mechanical aspiration for vegetation debulking in patients with right-sided infective endocarditis, demonstrating favorable procedural outcomes but potential risks of embolization and leaflet injury.
Original Research
Jul 15
Gregory P. Fontana, Raj Makkar, et al.
This study compared the haemodynamic performance and prosthesis-patient mismatch of three transcatheter aortic valves (Portico, Evolut, SAPIEN 3) in patients with small and large aortic annuli. Portico and Evolut had similar outcomes, while Portico outperformed SAPIEN 3 in both annulus sizes.
Original Research
Jul 13
Binhao Wang, Huimin Chu, et al.
The SAFE-PROTECT trial found that the novel AnchorMan left atrial appendage closure device was non-inferior to the Watchman 2.5 device in terms of clinical success and LAA occlusion rates in patients with non-valvular atrial fibrillation at high risk of ischemic stroke.
Research Correspondence
Jul 10
Manveer Singh, Philippe Garot, et al.
This study examines the use of transcatheter aortic valve implantation (TAVI) across different surgical risk levels, reporting risk ratios and confidence intervals.
Jun 23
EuroIntervention confirms its strong scientific impact. Learn more about EuroIntervention's latest Impact Factor, CiteScore and Altmetric performance.
Editorial
Jul 14
Philippe Garot, Jens Erik Nielsen-Kudsk
The SAFE-PROTECT trial compared a novel left atrial appendage closure device (AnchorMan) to an earlier generation device, suggesting potential advantages in sealing performance, but requiring further investigation to determine clinical implications.
free
Editorial
Jul 8
Daniel J. Blackman, Annette Maznyczka
The study compared the clinical and hemodynamic outcomes of two self-expanding transcatheter aortic valve types - the intra-annular Navitor/Navitor Vision and the supra-annular Evolut FX/Evolut FX+ - in a propensity-matched cohort of 892 patients.
free
Original Research
Jul 7
Matteo Casenghi, Emanuele Barbato, et al.
This study compared 1-year clinical and hemodynamic outcomes between intra-annular and supra-annular self-expanding transcatheter heart valves, finding similar results despite differences in procedural safety profiles.
new issue
Jul 6
AnchorMan vs Watchman for LAA closure; TAVI with intra- or supra-annular self-expanding valves; prosthesis-patient mismatch after TAVI; VARC-HBR validation; percutaneous mechanical aspiration in left-sided infective endocarditis; concomitant transfemoral TAVI and TMVR; and more
Editorial
Jul 2
Anna Sonia Petronio, Matteo Mazzola, et al.
The PRIME-MR registry highlights progress in the safety and early efficacy of M-TEER for primary mitral regurgitation, but underscores a persistent gap between procedural success and proven durability.
free
Original Research
Jun 29
Benedikt Koell, Daniel Kalbacher, et al.
The study analyzed temporal trends in the safety, efficacy, and stability of mitral valve transcatheter edge-to-edge repair for primary mitral regurgitation, finding improved procedural safety, enhanced efficacy, and greater durability of results over time.
